检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:董国明
出 处:《中国药理学与毒理学杂志》2014年第5期758-764,共7页Chinese Journal of Pharmacology and Toxicology
摘 要:阿片受体激动剂羟考酮是强效麻醉性镇痛药,其镇痛作用强,但其耐受性、依赖性及其抑制胃肠道平滑肌蠕动等不良反应限制了其临床应用。自20世纪末,研究者开始分别将解热镇痛药、阿片受体激动剂、阿片受体拮抗剂、多巴胺受体拮抗剂等药物与羟考酮以不同比例进行组方,在增强镇痛作用的同时能降低羟考酮的用量并减少其不良反应,从而达到限制其滥用的目的。本文仅就羟考酮复方的发展进行较为系统的综述,以期为进一步促进其临床应用提供依据。Oxycodone,an opioid receptor agonist,is one of potent narcotic analgesics. Despite its potent analgesic effect,the tolerant and dependent liability of oxycodone as well as its inhibition on gas-trointestinal motility strongly restricts its clinical application. Since the end of the last century,antipyretic, opioid receptor agonist,opioid receptor antagonist and dopamine receptor antagonist have been used to in combination with oxycodone at different ratios as complex prescriptions,the aim of which is to enhance the effect of oxycodone,decrease the dosage of oxycodone,and prevent the adverse effect and the tendency for misuse. Here we reviewed the development of oxycodone compositions in the recent years,hoping to provide more data for its potential clinical application.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.17.156.114